SGMS1 and central nervous system cancer: Despite similar enzymatic activity, SMS1 and SMS2 have a divergent influence on glioma patients’ overall survival, and this divergence is possibly associated with the different roles in cancer (and possibly normal) cell differentiation, proliferation and survival.